BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9175606)

  • 1. Stereoselective increase in cholinergic transmission by R-(+)-hyoscyamine.
    Ghelardini C; Gualtieri F; Novella Romanelli M; Angeli P; Pepeu G; Grazia Giovannini M; Casamenti F; Malmberg-Aiello P; Giotti A; Bartolini A
    Neuropharmacology; 1997 Mar; 36(3):281-94. PubMed ID: 9175606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive and antiamnesic properties of the presynaptic cholinergic amplifier PG-9.
    Ghelardini C; Galeotti N; Gualtieri F; Marchese V; Bellucci C; Bartolini A
    J Pharmacol Exp Ther; 1998 Mar; 284(3):806-16. PubMed ID: 9495837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
    Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
    Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive profile of 3-alpha-tropanyl 2-(4-Cl-phenoxy)butyrate (SM-21) [corrected]: a novel analgesic with a presynaptic cholinergic mechanism of action.
    Ghelardini C; Galeotti N; Gualtieri F; Bellucci C; Manetti D; Giotti A; Malmberg-Aiello P; Galli A; Bartolini A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):430-9. PubMed ID: 9223584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The (S)-(+)-enantiomer of dimethindene: a novel M2-selective muscarinic receptor antagonist.
    Pfaff O; Hildebrandt C; Waelbroeck M; Hou X; Moser U; Mutschler E; Lambrecht G
    Eur J Pharmacol; 1995 Nov; 286(3):229-40. PubMed ID: 8608784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic, antimuscarinic activity and enantioselectivity of the four isomers of 3-quinuclidinyl tropate as compared with the enantiomers of hyoscyamine.
    Dei S; Bellucci C; Gualtieri F; Romanelli MN; Scapecchi S; Teodori E; Bartolini A; Ghelardini C
    Farmaco; 1995 May; 50(5):303-9. PubMed ID: 7626164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation into atropine-induced antinociception.
    Ghelardini C; Malmberg-Aiello P; Giotti A; Malcangio M; Bartolini A
    Br J Pharmacol; 1990 Sep; 101(1):49-54. PubMed ID: 2282466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
    Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive effect of R-(+)-hyoscyamine on the conjunctival reflex test in rabbits.
    Ghelardini C; Galeotti N; Fantetti L; Gualtieri F; Scapecchi S; Bartolini A
    Jpn J Pharmacol; 1999 Sep; 81(1):34-7. PubMed ID: 10580368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of M2 and M4 muscarinic receptors in regulating acetylcholine release from myenteric neurons of mouse ileum.
    Takeuchi T; Fujinami K; Goto H; Fujita A; Taketo MM; Manabe T; Matsui M; Hata F
    J Neurophysiol; 2005 May; 93(5):2841-8. PubMed ID: 15574798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The design and pharmacology of novel selective muscarinic agonists and antagonists.
    Lambrecht G; Gross J; Hacksell U; Hermanni U; Hildebrandt C; Hou X; Moser U; Nilsson BM; Pfaff O; Waelbroeck M
    Life Sci; 1995; 56(11-12):815-22. PubMed ID: 10188780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selectivity of the (-)-and (+)-forms of hyoscine methiodide and of hyoscyamine camphorsulphonate for muscarinic (M2) receptors.
    Barlow RB; Dawson S
    Br J Pharmacol; 1986 Oct; 89(2):439-44. PubMed ID: 3779219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtypes of muscarinic receptor on cholinergic nerves and atrial cells of chicken and guinea-pig hearts.
    Jeck D; Lindmar R; Löffelholz K; Wanke M
    Br J Pharmacol; 1988 Feb; 93(2):357-66. PubMed ID: 3359108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.
    Wess J; Lambrecht G; Mutschler E; Brann MR; Dörje F
    Br J Pharmacol; 1991 Jan; 102(1):246-50. PubMed ID: 2043926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective interaction of uncharged esters at four muscarinic receptor subtypes.
    Waelbroeck M; Hou X; Wehrle J; Mutschler E; Van Tilburg E; Menge W; Timmerman H; Lambrecht G
    Eur J Pharmacol; 1996 May; 303(3):221-6. PubMed ID: 8813573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
    Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
    Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M4 muscarinic autoreceptor-mediated inhibition of -3H-acetylcholine release in the rat isolated urinary bladder.
    D'Agostino G; Barbieri A; Chiossa E; Tonini M
    J Pharmacol Exp Ther; 1997 Nov; 283(2):750-6. PubMed ID: 9353395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of methoctramine, a muscarinic M2 receptor antagonist, on muscarinic and nicotinic cholinoceptors in guinea-pig airways in vivo and in vitro.
    Watson N; Barnes PJ; Maclagan J
    Br J Pharmacol; 1992 Jan; 105(1):107-12. PubMed ID: 1596672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of parafluorohexahydrosiladiphenidol at muscarinic receptors in vitro.
    Eglen RM; Michel AD; Montgomery WW; Kunysz EA; Machado CA; Whiting RL
    Br J Pharmacol; 1990 Apr; 99(4):637-42. PubMed ID: 2361166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological activity of methoctramine-related tetraamines bearing an 11-acetyl-5,11-dihydro-6H-pyrido[2,3-b][1,4] benzodiazepin-6-one moiety: structural requirements for optimum occupancy of muscarinic receptor subtypes as revealed by symmetrical and unsymmetrical polyamines.
    Minarini A; Bolognesi ML; Budriesi R; Canossa M; Chiarini A; Spampinato S; Melchiorre C
    J Med Chem; 1994 Sep; 37(20):3363-72. PubMed ID: 7932564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.